Peter Albers, MD, is Professor and Chairman of the Department of Urology, Heinrich-Heine-University Düsseldorf since 2008. In January 2018 he was elected Medical Director of the CIO Düsseldorf, Comprehensive Cancer Center at the University Hospital Düsseldorf. In January 2020 he was double appointed Division Head of the newly established Division “Personalized Early Detection” in the National Cancer Prevention Center of the German Cancer Research Center (DKFZ) in Heidelberg. Prof. Albers received his MD degree from the University Mainz and started his surgical training and urological residency at the Universities of Mainz and Bonn. He obtained a German Research Foundation (DFG 391/1-3) Research Fellowship at the Department of Urology, Indiana University (Indianapolis) and at the Department of "Cancer Research" Eli Lilly, Inc. (Indianapolis, USA) as well as a Clinical Observership in Pediatric Urology at the Riley Hospital for Children Indianapolis and at the Children´s Hospital of Philadelphia and Urologic Oncology at the Memorial Sloan Kettering Cancer Center (New York City, USA).
From 1998-2003 Prof. Albers was Vice Chairman of the Department of Urology at the University of Bonn and from 2003-2008 Chairman of the Department of Urology at the Klinikum Kassel GmbH, Marburg University. Since 2008 he is Professor and Chairman of the Department of Urology at the Heinrich-Heine-University Düsseldorf. Peter Albers received numerous awards, such as the Maximilian-Nitze-Award of the German Society of Urology in 1999 and 2002, the Alken Prize and the John-Mendelsohn Study-Award of the German Cancer Society in 2010.
Prof. Albers led the EAU Testis Cancer Guidelines Group from 2006 to 2018 and chaired as Congress President the German Cancer Congress in 2012. From 2016 to 2018 Peter Albers was President of the German Cancer Society. 2019 he was appointed Chair of the Scientific Congress Office and Board Member of the European Association of Urology (EAU).
Updated: May 2021